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In 2005, 13.5% of clinic-admitted raptors in northern
Colorado tested positive for West Nile virus (WNV). Clinic-
admitted–raptor surveillance detected WNV activity nearly
14 weeks earlier than other surveillance systems. WNV
surveillance using live raptor admissions to rehabilitation
clinics may offer a novel surveillance method and should be
considered along with other techniques already in use.
W
est Nile virus (WNV; genus Flavivirus; family
Flaviviridae) is an emerging pathogen of public
health and veterinary importance. In North America, WNV
has been associated with death in >198 species of birds,
including >33 species of raptors (1). Many hawk and owl
species are known to survive WNV infection (2–5).
Presumably most raptors become infected from mosquito
bites; however, some evidence suggests that infection may
occur after consumption of infected prey items (2,4–6).
Thus, raptors may be infected at a greater rate than nonrap-
tors. Dead raptors and other birds (particularly corvids)
have been used for early detection of WNV activity (7).
However, once WNV activity is established in a location,
birds that are highly susceptible to fatal infection are
removed from the environment, and as a result, avian death
rates should diminish (8). Raptors infected with WNV that
are admitted to rehabilitation facilities, either because of
WNV-associated illness or injury or for other unrelated
complications, may serve as an alternate source for early
detection of WNV infection.
The Study
From 2002 through 2005, raptors originating in
Colorado were bled by ulnar venipuncture and orally
swabbed upon admission to the Rocky Mountain Raptor
Program of Colorado State University. WNV was first
detected in Colorado in August 2002, and testing of raptors
was initiated in September (oral swabs) and October
(serum samples). In all other years, samples were collect-
ed from early to late April through mid to late October.
Specimens were tested for WNV-neutralizing antibodies
by plaque-reduction neutralization test (PRNT) and for
virus isolation by Vero cell plaque assay (9) or WNV anti-
gen by VecTest WNV Antigen Detection Assay (Medical
Analysis Systems, Ventura, CA, USA). Isolated viruses
were identified as WNV by VecTest. To confirm that anti-
body-positive adult raptors were recently infected, we
evaluated 90% neutralization titers in acute-phase and con-
valescent-phase serum samples collected ≈3 weeks apart.
A 4-fold increase in titer was considered evidence of a
recent infection. Cross-reactivity for another closely relat-
ed North American flavivirus, Saint Louis encephalitis
virus, was ruled out by comparing 90% neutralization
titers. A 4-fold greater titer for 1 of the viruses indicated
that particular virus as the etiologic agent for the infection.
Utility of WNV detection in raptors was evaluated in rela-
tion to other existing WNV surveillance techniques in
northern Colorado.
We report results from 323 raptors sampled from
2002 through 2005. Most of these (83%) originated from
Weld and Larimer counties, which represent an area of
6,639 square miles, larger than Connecticut and Rhode
Island combined. During the study, 38 raptors (11.8%)
tested positive for WNV. Some were positive by both oral
swab and seroconversion, while others were positive
according to only 1 of these. Usually, birds that were pos-
itive only by oral swab died before 1 or both blood sam-
ples could be collected, so we were unable to test for
seroconversion.
In 2002, 17 raptors were tested (blood by PRNT and
oral swab by plaque assay), 4 of which were seropositive
for WNV between October 7 and November 15. In 2003,
52 birds were tested (serum by PRNT and oral swab by
VecTest), 7 of which seroconverted and 5 of which were
oral swab–positive. Positive samples were detected
between July 17 and September 1. In 2004, 113 birds were
tested by plaque assay of oral swab (no blood test), and 3
were found to be positive between July 28 and September
17. In 2005, 141 birds were tested (serum by PRNT and
oral swab by plaque assay), of which 19 were positive (8
by seroconversion, 6 by virus isolation from swab, and 5
by both methods; Table). Positive results were from birds
admitted between April 8 and September 21.
To compare our test results with those from other sur-
veillance systems for WNV, we limited our data to speci-
mens collected April 1–October 15, 2005, from raptors
originating in Weld or Larimer counties. In comparing the
earliest date of detection for each of the surveillance meth-
ods in place in these counties, clinic-admitted raptor sur-
veillance provided the earliest evidence of WNV activity
(April 8), preceding all other WNV surveillance systems’
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(Figure).
Conclusions
The early detection of WNV in clinic-admitted raptors
compared with other detections by surveillance systems in
northern Colorado during 2005 points to the potential util-
ity of raptor rehabilitation centers for WNV surveillance.
Although other active surveillance systems require signif-
icant allocations of human resources, clinic-admitted rap-
tor surveillance is a passive system that takes advantage of
existing resources outside the traditional public health
infrastructure. Nationwide, about 1,000 wildlife rehabilita-
tion facilities admit ≈10,000 birds annually (P. Redig, pers.
comm.). Participation in surveillance efforts provides reha-
bilitators with valuable diagnostic information and can be
accomplished at no cost to the rehabilitator, provided that
provisions are supplied.
The detection of WNV in an oral swab of a great
horned owl in early April in Colorado was quite unexpect-
ed because of the early date. This bird was an uninjured
nestling that was brought to the clinic for nurturing until it
could be replaced into its original nest. The oral swab
yielded a low number of infectious virus particles (2.5
PFU), and the nestling failed to develop clinical signs and
failed to seroconvert. We believe that the oral cavity may
have been contaminated by a recent prey meal provided by
the bird’s parents shortly before admission. Although early
spring transmission of WNV by mosquitoes to either the
owlet or a prey animal is possible, persistent infection of
the prey item is an alternative explanation. Experimentally
infected hamsters develop chronically infected kidneys
(10), and birds may also maintain persistent visceral infec-
tions (2).
If the early detection in the owl was an anomaly, the
next earliest evidence of WNV activity from clinic-admit-
ted raptors was June 28, which also preceded all other
detections. The first confirmed human case of West Nile
fever in the study area developed symptoms on July 17,
and the first confirmed case of West Nile neurologic dis-
ease occurred on August 6 (Figure).
Although we have shown that a combination of sero-
logic and oral swab testing increases the sensitivity of clin-
ic-admitted raptor surveillance almost 2-fold, serologic
testing has 3 important limitations: 1) blood sampling
requires special training and expertise; 2) evidence of sero-
conversion requires 2 samples spaced apart by at least 2
weeks, and therefore reporting of positive results is signif-
icantly delayed by several weeks after onset of infection;
and 3) neutralization tests can be prohibitively expensive
and require extensive training, time, supplies, Biosafety
Level-3 (BSL-3) lab facilities, and expertise in interpreting
results, which are complicated by cross-reactions with
closely related viruses. Limiting sampling to oral swabs
reduces sensitivity; however, the savings in time and cost
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Figure. Chronology of detections of West Nile virus by various sur-
veillance systems in place in Larimer and Weld Counties, northern
Colorado, 2005. Confirmed human cases, mosquito, dead bird,
and equine surveillance information provided by the Centers for
Disease Control and Prevention's ArboNet Surveillance System
through October 15, 2005.would permit a greater number of samples to be collected
and tested. Although we used plaque assay for detecting
WNV in oral swabs, which also requires BSL-3 laboratory
facilities, our samples could have been tested with high
sensitivity and specificity for WNV-specific RNA
sequences by using reverse transcription–PCR, which
requires a lower level of biosafety (11).
In conclusion, limited data from 1 small region of
North America suggest that WNV surveillance using live
raptor admissions to rehabilitation facilities should be con-
sidered along with other established surveillance methods
already in use (12,13). Clinic-admitted raptors are most
useful for early detection or continued detection of WNV
activity. However, this form of surveillance is inadequate
for quantifying local transmission risk.
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